{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:17:55Z","timestamp":1740107875124,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s15010-020-01470-z","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:45:34Z","timestamp":1593186334000},"page":"799-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient"],"prefix":"10.1007","volume":"48","author":[{"given":"Deborah","family":"Eshagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Benali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Paule","family":"Chauveheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Rouzaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiphaine","family":"Goulenok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Papo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-234X","authenticated-orcid":false,"given":"Karim","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"1470_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijid.2014.12.030","volume":"32","author":"LC Bell","year":"2015","unstructured":"Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis. 2015;32:39\u201345.","journal-title":"Int J Infect Dis"},{"key":"1470_CR2","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/01.aids.0000202648.18526.bf","volume":"20","author":"A Bourgarit","year":"2006","unstructured":"Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS. 2006;20:F1\u20137.","journal-title":"AIDS"},{"key":"1470_CR3","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry. Arthritis Rheum. 2009;60:1884\u201394.","journal-title":"Arthritis Rheum"},{"key":"1470_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1086\/517519","volume":"195","author":"HL Plessner","year":"2007","unstructured":"Plessner HL, Lin PL, Kohno T, et al. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J Infect Dis. 2007;195:1643\u201350.","journal-title":"J Infect Dis"},{"key":"1470_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/COH.0b013e32833ed774","volume":"5","author":"I Sereti","year":"2010","unstructured":"Sereti I, Rodger AJ, French MA. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS. 2010;5:504\u201310.","journal-title":"Curr Opin HIV AIDS"},{"key":"1470_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1473-3099(15)70008-3","volume":"15","author":"S Ravimohan","year":"2015","unstructured":"Ravimohan S, Tamuhla N, Steenhoff AP, et al. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. Lancet Infect Dis. 2015;15:429\u201338.","journal-title":"Lancet Infect Dis"},{"key":"1470_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jbspin.2015.04.022","volume":"83","author":"C Rivoisy","year":"2016","unstructured":"Rivoisy C, Tubach F, Roy C. Paradoxical anti-TNF-associated TB worsening: frequency and factors associated with IRIS. Joint Bone Spine. 2016;83:173\u20138.","journal-title":"Joint Bone Spine"},{"key":"1470_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/598504","volume":"48","author":"RS Wallis","year":"2009","unstructured":"Wallis RS, van Vuuren C, Potgieter S. Adalimumab treatment of life-threatening tuberculosis. Clin Infect Dis. 2009;48:1429\u201332.","journal-title":"Clin Infect Dis"},{"key":"1470_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cid\/civ841","volume":"62","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Faldetta KF, Pei L, et al. A paradoxical treatment for a paradoxical condition: infliximab use in three cases of mycobacterial IRIS. Clin Infect Dis. 2016;62:258\u201361.","journal-title":"Clin Infect Dis"},{"key":"1470_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/QAD.0000000000000634","volume":"29","author":"C Richaud","year":"2015","unstructured":"Richaud C, Ghosn J, Amazzough K, Poiree S, Lortholary O. Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS. AIDS. 2015;29:1117\u20139.","journal-title":"AIDS"},{"key":"1470_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/430914","volume":"41","author":"RS Wallis","year":"2005","unstructured":"Wallis RS. Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis. 2005;41:201\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01470-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-020-01470-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01470-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:49:43Z","timestamp":1624664983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-020-01470-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s15010-020-01470-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"type":"print","value":"0300-8126"},{"type":"electronic","value":"1439-0973"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Consent was obtained from the patient to publish these images and clinical history.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}